Astodrimer, also known as SPL7013, a microbicide developed by Starpharm. This drug has been used in phase III clinical trials for the treatment and prevention of Bacterial Vaginosis. Starpharma conducts a meeting with US FDA related to potential approval of astodrimer in Bacterial vaginosis. In addition, SPL7013, participated in phase II clinical trials against human immunodeficiency virus (HIV) and herpes simplex virus 2 (genital herpes, HSV-2). It is known that astodrimer binds tightly to R5 gp120 in the gp120-CD4 complex, thus preventing the accrual of the requisite number of gp120-CD4 complexes across the virus-cell interface, thereby blocking virus entry.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| The SPL7013 dendrimer destabilizes the HIV-1 gp120-CD4 complex. | 2015-11-28 |
|
| SPL7013 Gel (VivaGel®) retains potent HIV-1 and HSV-2 inhibitory activity following vaginal administration in humans. | 2011 |
|
| SPL7013 gel as a topical microbicide for prevention of vaginal transmission of SHIV89.6P in macaques. | 2005-03 |
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT01577537
1% SPL7013 (ASTODRIMER) vaginal gel, daily for 7 days
Route of Administration:
Vaginal
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
300000021737
Created by
admin on Mon Mar 31 22:53:52 GMT 2025 , Edited by admin on Mon Mar 31 22:53:52 GMT 2025
|
PRIMARY | |||
|
DBSALT002095
Created by
admin on Mon Mar 31 22:53:52 GMT 2025 , Edited by admin on Mon Mar 31 22:53:52 GMT 2025
|
PRIMARY | |||
|
CHEMBL2364666
Created by
admin on Mon Mar 31 22:53:52 GMT 2025 , Edited by admin on Mon Mar 31 22:53:52 GMT 2025
|
PRIMARY | |||
|
C480351
Created by
admin on Mon Mar 31 22:53:52 GMT 2025 , Edited by admin on Mon Mar 31 22:53:52 GMT 2025
|
PRIMARY | |||
|
8Q3B8SV59L
Created by
admin on Mon Mar 31 22:53:52 GMT 2025 , Edited by admin on Mon Mar 31 22:53:52 GMT 2025
|
PRIMARY | |||
|
C188539
Created by
admin on Mon Mar 31 22:53:52 GMT 2025 , Edited by admin on Mon Mar 31 22:53:52 GMT 2025
|
PRIMARY | |||
|
ZZ-169
Created by
admin on Mon Mar 31 22:53:52 GMT 2025 , Edited by admin on Mon Mar 31 22:53:52 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD